TY - JOUR
T1 - Splenic CD4+ T Cells Have a Distinct Transcriptional Response Six Hours after the Onset of Sepsis
AU - McDunn, Jonathan E.
AU - Turnbull, Isaiah R.
AU - Polpitiya, Ashoka D.
AU - Tong, Alice
AU - MacMillan, Sandra K.
AU - Osborne, Dale F.
AU - Hotchkiss, Richard S.
AU - Colonna, Marco
AU - Cobb, J. Perren
N1 - Funding Information:
This work was supported in part by the NIH (R01 GM59960) (JPC), the Clowes Career Development Award from the American College of Surgeons (JPC), and the Ruth Kirschstein National Research Service Award Training Program in Critical Care (T32 GM08795) (JEM).
PY - 2006/9
Y1 - 2006/9
N2 - Background: In animal and human autopsy studies of sepsis, CD4+ splenocytes either undergo apoptosis or are polarized to the Th2 effector subtype. In mice, these changes occur within 24 hours of the onset of sepsis. Preventing the loss of CD4+ T cells and the Th2-polarization of CD4+ T cells provides a significant survival advantage in mouse models of sepsis. The molecular mechanism(s) for the phenotypic changes of splenic CD4+ T cells in sepsis are not well understood. Study design: CD4+ splenocytes were enriched by negative selection from disaggregated spleens of septic and sham-operated mice at 6 and 24 hours after surgery. Phenotypic analysis using cell surface markers (CD25, CD44, CD62L, CD69), cytokine secretion in response to CD3/CD28 coligation, and whole genome microarray gene expression profiles were obtained for these cells. Results: Consistent with previous reports, sepsis induced a progressive decrease in the number of CD4+ splenocytes and a time-dependent alteration in CD4+ T-cell phenotype. At 6 hours, when no differences in cell number or surface marker expression were observed, significant alterations in RNA abundance were measured for 498 probe sets. Ontologic classification of these genes indicated changes in cellular physiology. Pathway analysis indicated that T-cell receptor signaling and mitogen-activated protein kinase signaling were significantly altered by sepsis. Conclusions: These data demonstrated a sepsis-specific transcriptional program that precedes sepsis-induced phenotypic changes in CD4+ splenocytes.
AB - Background: In animal and human autopsy studies of sepsis, CD4+ splenocytes either undergo apoptosis or are polarized to the Th2 effector subtype. In mice, these changes occur within 24 hours of the onset of sepsis. Preventing the loss of CD4+ T cells and the Th2-polarization of CD4+ T cells provides a significant survival advantage in mouse models of sepsis. The molecular mechanism(s) for the phenotypic changes of splenic CD4+ T cells in sepsis are not well understood. Study design: CD4+ splenocytes were enriched by negative selection from disaggregated spleens of septic and sham-operated mice at 6 and 24 hours after surgery. Phenotypic analysis using cell surface markers (CD25, CD44, CD62L, CD69), cytokine secretion in response to CD3/CD28 coligation, and whole genome microarray gene expression profiles were obtained for these cells. Results: Consistent with previous reports, sepsis induced a progressive decrease in the number of CD4+ splenocytes and a time-dependent alteration in CD4+ T-cell phenotype. At 6 hours, when no differences in cell number or surface marker expression were observed, significant alterations in RNA abundance were measured for 498 probe sets. Ontologic classification of these genes indicated changes in cellular physiology. Pathway analysis indicated that T-cell receptor signaling and mitogen-activated protein kinase signaling were significantly altered by sepsis. Conclusions: These data demonstrated a sepsis-specific transcriptional program that precedes sepsis-induced phenotypic changes in CD4+ splenocytes.
UR - http://www.scopus.com/inward/record.url?scp=33747354946&partnerID=8YFLogxK
U2 - 10.1016/j.jamcollsurg.2006.05.304
DO - 10.1016/j.jamcollsurg.2006.05.304
M3 - Article
C2 - 16931309
AN - SCOPUS:33747354946
SN - 1072-7515
VL - 203
SP - 375.e1-375.e39
JO - Journal of the American College of Surgeons
JF - Journal of the American College of Surgeons
IS - 3
ER -